Arrowstreet Capital’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-18,725
| Closed | -$575K | – | 1356 |
|
|
2022
Q3 | $575K | Buy |
+18,725
| New | +$575K | ﹤0.01% | 1086 |
|
|
2021
Q4 | – | Sell |
-96,868
| Closed | -$4.89M | – | 1497 |
|
|
2021
Q3 | $4.89M | Buy |
+96,868
| New | +$4.89M | 0.01% | 946 |
|
|
2021
Q2 | – | Sell |
-85,607
| Closed | -$4.89M | – | 1960 |
|
|
2021
Q1 | $4.89M | Sell |
85,607
-44,232
| -34% | -$2.53M | 0.01% | 1184 |
|
|
2020
Q4 | $10.9M | Buy |
129,839
+74,368
| +134% | +$6.23M | 0.02% | 848 |
|
|
2020
Q3 | $1.99M | Buy |
+55,471
| New | +$1.99M | ﹤0.01% | 1555 |
|
|
2020
Q1 | – | Sell |
-33,242
| Closed | -$579K | – | 1922 |
|
|
2019
Q4 | $579K | Buy |
+33,242
| New | +$579K | ﹤0.01% | 1469 |
|
|
2019
Q2 | – | Sell |
-50,333
| Closed | -$1.17M | – | 1455 |
|
|
2019
Q1 | $1.17M | Buy |
+50,333
| New | +$1.17M | ﹤0.01% | 1276 |
|